Sort
40,608 grants matching “prostate cancer”
AR gene rearrangements and AR signaling in prostate cancer
$366,539Scott M. Dehm · University Of Minnesota · R01 · FY2018 · CA
Project 1: Combined Suppression of MYC as therapy for CRPC: the COSMYC trial
$366,533Samuel R Denmeade · Johns Hopkins University · P50 · FY2024 · CA
Trk Expression and Inhibition in Human Neuroblastomas
$366,503Garrett M Brodeur · Children'S Hosp Of Philadelphia · R01 · FY2012 · CA
Managed Care Penetration and Cancer Care
$366,483Harvard University (Medical School) · R01 · FY2001 · CA
Converting Cold to Hot Tumor Microenvironment in Prostate Cancer by Targeting Chromatin Effector
$366,441Xin Lu · University Of Notre Dame · R01 · FY2020 · CA
Project 1: Modeling tumor evolution in mouse and organoid models
$366,414Raul Rabadan · Columbia University Health Sciences · U54 · FY2015 · CA
Pure Flavonolignans from S. marianum in Prostate Cancer
$366,377Research Triangle Institute · R01 · FY2004 · CA
Opening the Therapeutic Window for PSMA-Targeted Molecular Radiotherapy
$366,376Daniel Lyndon Jaffe Thorek · Washington University · R01 · FY2022 · CA
Immunogenic Priming with Lu-PSMA Targeted Therapy in Advanced Prostate Cancer
$366,367Rahul Aggarwal · University Of California, San Francisco · R01 · FY2019 · CA
Towards Understanding Prostate Cancer Heterogeneity
$366,367Mark A. Rubin · Weill Medical Coll Of Cornell Univ · R01 · FY2014 · CA
P13K/PTEN/Akt signaling and the genesis of cancer
$366,329Nissim Hay · University Of Illinois At Chicago · R01 · FY2017 · CA
Role of proinflammatory cytokine-induced AR degradation in castration-resistant prostate cancer
$366,296Haojie Huang · Mayo Clinic Rochester · R01 · FY2019 · CA
Growth Hormone Receptor Dimerization & Disulfide Linkage
$366,250Stuart J. Frank · University Of Alabama At Birmingham · R01 · FY2011 · DK
Intrinsic anti-angiogenic activity of siRNA
$366,250Jayakrishna Ambati · University Of Kentucky · R01 · FY2009 · EY
Pten-loss Dysregulated Pathways in Prostate Cancer
$366,250Zhenbang Chen · Meharry Medical College · R01 · FY2010 · MD
Intrinsic anti-angiogenic activity of siRNA
$366,250Jayakrishna Ambati · University Of Kentucky · R01 · FY2008 · EY
Role of Fetuin-A in Tumor Cell Growth
$366,250Josiah Ochieng · Meharry Medical College · SC1 · FY2007 · CA
Role of Fetuin-A in Tumor Cell Growth
$366,250Josiah Ochieng · Meharry Medical College · SC1 · FY2008 · CA
Role of Fetuin-A in Tumor Cell Growth
$366,250Josiah Ochieng · Meharry Medical College · SC1 · FY2009 · CA
Role of Fetuin-A in Tumor Cell Growth
$366,250Josiah Ochieng · Meharry Medical College · SC1 · FY2010 · CA
Pten-loss Dysregulated Pathways in Prostate Cancer
$366,250Zhenbang Chen · Meharry Medical College · R01 · FY2009 · MD
Men of African Ancestry are primed for aggressive prostate cancer by high prostate androgens driven by vitamin D deficiency and megalin
$366,242Larisa Nonn · University Of Illinois At Chicago · R01 · FY2024 · CA
The role and mechanism of RNA m6A modification in the pathogenesis and drug-resistance of prostate cancer
$366,240Jihoon Lee · University Of Texas Hlth Science Center · R01 · FY2024 · CA
Project 2: Androgen deprivation as an immune modulating therapy in combination with targeted immunotherapy of prostate cancer
$366,237Douglas G McNeel · University Of Wisconsin-Madison · P50 · FY2025 · CA
PROSTATE CANCER--EXPOSURE, SUSCEPTIBILITY AND DNA ADDUCT
$366,235University Of Arkansas Med Scis Ltl Rock · R01 · FY2001 · AG